VEGFA and macular retinal edema: The CRUISE and COPERNICUS trials demonstrate the effectiveness of anti-VEGF for macular edema resulting from CRVO, and the results from these studies imply that ocular NV and NVG are reduced from the administration of anti-VEGF, which is both logical and promising.